web analytics
13.3 C
Munich
Sunday, September 25, 2022

Stemtech Corp (OTCMKTS: STEK) Globe Net Wireless RM Massive Drop as Promo Losses Steam

Stemtech Corp (OTCMKTS: STEK) has seen a significant drop in recent weeks after rocketing up to $11.50 per share earlier this month. We stated in our first article on STEK on August 8 when the stock was around $8 per share: “STEK is a major league promotion from some heavy hitters that could easily go much higher but when the bottom falls out, it could drop fast.” It did go higher, another $3 or so from where we wrote about it but the bottom did fall out and it’s been a precipitous collapse to just over $3 per share. While STEK has a real business and is doing over $1 million a quarter in sales, the stock was being heavily promoted with STEK reaching a valuation of $500 million, a valuation the stock could not possibly maintain. Even at current levels of $167 million valuation STEK has little fundamentals to back it up and could drop significantly further. It may see significant bounces to the upside on the way down reaching a 100% or more considering how fast it has dropped. 

The Company acknowledged the promotion in the July press release stating: “”At close of business this past Friday, July 8th, OTC Markets notified our Company of a foreign stock promotion which we were unaware of, and provided Stemtech Corporation with a copy of an article from a UK web site called “World Finance”, which emphatically predicted share price appreciation in the Stem Cell arena in general, and our Company in particular. This promotion apparently based their material solely upon the past history of one of our Directors from publicly available material. Neither the Board nor our sole IR specialist, Winthorp Capital, have any knowledge of or involvement with said unknown third-party promotion; and would have remained ignorant of it but for the notice received from OTC Markets. According to the copy of the promotion provided for review by OTCMarkets, the web site publishing the stock promotion was www.world-financial-times.com. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Stemtech Corp (OTCMKTS: STEK) is a global network marketing company that develops science-based products that it believes supports wellness by helping the body maintain healthy stem cell physiology, also known as stem cell enhancers. Known as the Stem Cell Nutrition Company®, the Company is a pioneer in stem cell science, and believes it can demonstrate that adult stem cells function as the natural renewal system of the body. The Company believes its products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. The Company’s mission is to enhance wellness and prosperity around the world. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The Company markets its products under the following brands: RCM System, stemrelease3™, Stemflo® MigraStem™, DermaStem®, DermaStem Lift, OraStem® (Oral Health Care), and D-Fuze™. 

Stemtech has pioneered and patented a whole new category of dietary supplements. Stemtech’s advanced Stem Cell Nutrition formulations are one-of-a-kind natural products designed to help support the three most important aspects of stem cell physiology: 1) Releasing more stem cells; 2) their circulation in the blood; and 3) Migration into tissues, where they can perform their daily function of renewal and rejuvenation for optimal health. We actually harness the incredible power of adult stem cells. How does this work? Adult stem cells are released from your bone marrow into the bloodstream, they then Circulate in the bloodstream and flow to the tissues most in need. As they arrive, the adult stem cells migrate into the tissues, reproduce and become new, healthy cells of those tissues. This process takes place every single day, even without tissue damage, as part of the natural renewal system of the body. It is important to understand that Stemtech’s products do not contain stem cells. They are composed of natural botanicals and other ingredients that have been clinically documented to support the performance of your own adult stem cells.  STEK is now reengaging over 200,000 former distributors since a recent cash infusion. STEK has engaged experienced marketing and social media professionals to initiate new marketing strategies which are expected to bring increased activity. Moreover, it is now better positioned to absorb significant new clientele as the company has directed significant cash towards our inventory, and we now have enough inventory on hand to fulfill over $3 million dollars’ worth of new orders, an inventory level we have not had since going into bankruptcy in 2017. Management conservatively believes that given the cash on hand and working expenditures as describe above, it can reinvigorate sales to be more consistent with the company’s previous revenue historically, as it was recognized 4 times in the Inc 5000 Magazine’s list of fastest growing companies. 

On July 13 STEK issued a press release acknowledging and denying and involvement in the promotion stating: “At close of business this past Friday, July 8th, OTC Markets notified our Company of a foreign stock promotion which we were unaware of, and provided Stemtech Corporation with a copy of an article from a UK web site called “World Finance”, which emphatically predicted share price appreciation in the Stem Cell arena in general, and our Company in particular. This promotion apparently based their material solely upon the past history of one of our Directors from publicly available material. Neither the Board nor our sole IR specialist, Winthorp Capital, have any knowledge of or involvement with said unknown third-party promotion; and would have remained ignorant of it but for the notice received from OTC Markets. According to the copy of the promotion provided for review by OTCMarkets, the web site publishing the stock promotion was www.world-financial-times.com. The Company has reviewed said release and determined that the information posted was obtained from public information, the Company’s website and possibly certain filings by the Company with the SEC. The statements regarding the potential meteoric rise in our share price is specious and baseless, and by any objective standard should be ignored. In spite of the fact that the Company wholly disavows any knowledge of or connection to this release, the facts disclosed therein regarding our CEO’s business accomplishments are in fact accurate. Neither the Company or any its Officers or third-party consultants had any knowledge of, or were involved in any way, with this promotion. 

To Find out the inside Scoop on STEK Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

STEK

STEK has been busy; the Company recently got OraStem®, Stemtech’s all-natural toothpaste trademarked registered in Mexico. OraStem is composed of fourteen natural, non-GMO, and organic ingredients: powerful antioxidants, botanicals, herbal extracts, CoQ10, vitamins, and natural flavors. Their efficacy and safety for oral health have been supported by dozens of studies published in peer-reviewed journals. Stemtech will also be introducing a new sample / travel size of OraStem soon. 

Stemtech specializes in creating products and formulas that are patent protected in the U.S. and international markets. Its patented formulas help the release, circulation and migration of the body’s adult stem cells from the bone marrow. Also offered is the OraStem and D-Fuze, an Electro Magnetic Field blocker. Its nutraceutical products are all-natural, plant-based and manufactured under cGMP (Current Good Manufacturing Practices) under the auspices of the Dietary Supplemental Health and Education Act (DSHEA). Stemtech has a history of innovation and was the first to market in the category of stem cell nutrition and was recognized four separate times by Inc. 5000 Fastest-Growing Companies list. Stemtech’s primary marketing and distribution channel is through a direct sales structure, which offers supplemental and residual income-earning potential to IBPs. 

On August 25 STEK announced it has sponsored ADVENT EXPO sponsored by ADVENT GALAXY Inc.  who plans to make ADVENT EXPO a central meeting place and center for important social interactions between people of different backgrounds and age groups. Underlying technology allows for merchants, consumers, and large enterprises to be replaced by a virtual EXPO in the metaverse. EXPO will cater to B2C+B2B+B2E= B2X, or simply stated B2All. Entertainment zones, meeting and interacting with your friends at a coffee shop in real time is the future. Conducting business in co-working spaces without leaving one’s house is the future. 

Stemtech Corporation President and COO, John W. Meyer, says that “Stemtech Corporation is excited to become a sponsor of ADVENT EXPO as it has become a central meeting place and center for important social interactions. Advent Expo’s underlying technology enables consumers and large enterprises access to a virtual EXPO in the metaverse. Such a platform provides tremendous exposure for Stemtech to be introduced to so many people who are looking for anti-aging, all-natural plant-based stem cell nutrition products, as well as an income earning opportunity.” Henry Val of Advent Expo commented that “the Expo has millions of viewers all around the world who are seeking to find opportunities to make a connection where health and finances are key, for Stemtech we believe we can add More Sales+More Leads + Avatars that Talk Like A Real Person +More Team Members.” 

 For More on STEK Subscribe Right Now!

Currently trading at a $167 million market valuation, STEK OS is 44,945,673 and the float is just 6,483,034 shares. STEK is an SEC filer and fully reporting OTCQB. The Company has just over $500,000 in the treasury and $5.1 million in assets vs. $9.5 million in liabilities. STEK is starting to book some solid revenues reporting $1,156,308 in sales for the 3 months ended March 31, 2022 up from $1,075,761 for the same period last year. STEK is a major leaque promotion from some heavy hitters that traded as high as $11.50 per share earlier this month before dropping down to $3 currently. STEK has a real business and is doing over $1 million a quarter in sales, the stock was being heavily promoted with STEK reaching a valuation of $500 million, a valuation the stock could not possibly maintain. Even at current levels of $167 million valuation STEK has little fundamentals to back it up and could drop significantly further. It may see significant bounces to the upside on the way down reaching a 100% or more considering how fast it has dropped. We will be updating on STEK when more details emerge so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in STEK either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.